The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.

H5N1 influenza is evolving rapidly, weakening the effectiveness of existing antibodies and increasing its potential threat to ...

Fragmented pandemic authority in the United States creates a complex regulatory landscape where federal and state powers ...

The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.

In a briefing to member states today, the head of the United Nations Food and Agriculture Organization (FAO) today urged ...

H5 Influenza Vaccines: What Needs to Be Done to Reduce the Risk of a Pandemic Sep. 4, 2024 — As the global threat of H5N1 influenza looms with outbreaks across species and continents including ...

The H5N1 influenza virus poses a significant threat to public health due to its potential to shift from an epidemic to a pandemic. Since its emergence in the 1990s, H5N1 has demonstrated a concerning ...

Previous exposures to older flu strains prime the immune system to produce antibodies against bird flu (H5N1).

The FDA is recommending that flu vaccines for the 2025-26 season be trivalent, protecting against two strains of influenza A and one of influenza B. “The FDA anticipates that there will be an ...

The spread of H5N1 highly pathogenic avian influenza, bringing losses of hundreds of millions of poultry worldwide with increased spillover into mammals, highlights the urgent need for strengthened ...

During the 2010-2011 to 2024-2025 influenza seasons, 9% of pediatric influenza-associated deaths had influenza-associated encephalopathy or encephalitis (IAE).